Mirum Pharmaceuticals (MIRM) Capital Expenditures (2019 - 2026)
Mirum Pharmaceuticals (MIRM) posted quarterly Capital Expenditures of $664000.0 for Q1 2026, up 1519.51% year-over-year from $41000.0 in Q1 2025, and up 10.67% quarter-over-quarter from $600000.0 in Q4 2025.
Mirum Pharmaceuticals (MIRM) Capital Expenditures (2019 - 2026) Analysis & Trends
Mirum Pharmaceuticals' Capital Expenditures history runs 8 years deep, the most recent figure standing at $664000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures rose 1519.51% year-over-year to $664000.0; the TTM figure through Mar 2026 stood at $1.6 million (up 54.46% YoY), while the FY2025 annual figure was $954000.0, down 3.93% from the prior year.
- Capital Expenditures for Q1 2026 stood at $664000.0, up from $600000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $779000.0 in Q2 2024, with the low at $13000.0 in Q1 2024.
- The 5-year median for Capital Expenditures is $97000.0 (2023), against an average of $214142.9.
- The sharpest annual moves came in 2022 and 2025: Capital Expenditures surged 7966.67% in 2022, then slumped 83.83% in 2025.
- Mirum Pharmaceuticals' Capital Expenditures stood at $242000.0 in 2022, then slumped by 71.9% to $68000.0 in 2023, then plunged by 70.59% to $20000.0 in 2024, then soared by 2900.0% to $600000.0 in 2025, then gained by 10.67% to $664000.0 in 2026.
- Business Quant data shows MIRM's Capital Expenditures at $664000.0 in Q1 2026, $600000.0 in Q4 2025, and $187000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Mirum Pharmaceuticals | 6.52 Bn | 6.08 Bn | 145.90 Mn | 23,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 23,000.00 |
| Jun 30, 2026 | 23,000.00 |
| Mar 31, 2026 | 664,000.00 |
| Mar 31, 2026 | 664,000.00 |
| Dec 31, 2025 | 600,000.00 |
| Dec 31, 2025 | 600,000.00 |
| Sep 30, 2025 | 187,000.00 |
| Sep 30, 2025 | 187,000.00 |
| Jun 30, 2025 | 126,000.00 |
| Jun 30, 2025 | 126,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Mar 31, 2025 | 41,000.00 |
| Dec 31, 2024 | 20,000.00 |
| Dec 31, 2024 | 20,000.00 |
| Sep 30, 2024 | 181,000.00 |
| Sep 30, 2024 | 181,000.00 |
| Jun 30, 2024 | 779,000.00 |
| Jun 30, 2024 | 779,000.00 |
| Mar 31, 2024 | 13,000.00 |
| Mar 31, 2024 | 13,000.00 |